Glucometer market forecast points to $26.77 billion by 2030

The global glucometer market reached $15.43 billion in 2025 and is projected to rise to $26.77 billion by 2030, according to The Business Research Company. Growth is being driven by diabetes prevalence, home monitoring, and new digital and AI-enabled glucose tools, with North America holding the largest regional share in 2025.

Why it matters: - Rising diabetes rates are expanding demand for blood glucose monitoring devices. - The market’s growth signals more spending on home care, digital diabetes management, and connected health tools. - The shift matters for patients, providers, and device makers as monitoring moves closer to real-time and at-home care.

What happened: - The Business Research Company released its Glucometer Market Report 2026 covering market size, trends, and global forecast for 2026-2035. - The glucometer market reached $15.43 billion in 2025. - The market is projected to grow to $17.25 billion in 2026. - The report projects the market will reach $26.77 billion by 2030, with a CAGR of 11.6%. - North America held the largest share of the global glucometer market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The 2025-to-2026 jump reflects a CAGR of 11.8%. - Historical growth is linked to rising diabetes prevalence, greater awareness of blood glucose monitoring, home healthcare adoption, affordable glucometers, and chronic disease management programs. - Forecast growth is tied to AI-enabled glucose monitoring devices, wearable health tech, digital diabetes platforms, personalized care, and telehealth integration. - Key trends include continuous glucose monitoring systems, non-invasive glucose measurement, mobile health apps, home-based monitoring, and real-time data analytics. - A glucometer, also called a glucose meter, is a portable device that measures blood sugar levels. - The device helps people with diabetes track glucose concentrations throughout the day. - Diabetes can damage the heart, eyes, kidneys, nerves, and blood vessels when blood glucose stays high. - The UK National Health Service reported in June 2024 that more than 549,000 additional people in England were identified as at risk of developing type 2 diabetes in 2023. - The NHS said the number of people registered with pre-diabetes in England rose to 3,615,330 in 2023 from 3,065,825 in 2022. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The report frames glucometers as part of a broader shift toward connected diabetes care rather than standalone test devices. - North America’s lead suggests the region has the strongest current demand base, while faster growth may come from digital health adoption and expanding diabetes screening elsewhere. - The pre-diabetes figures in England underscore how rising risk populations can translate into future monitoring demand.

What's next: - The market is expected to keep growing through 2030 as diabetes management becomes more digital and more home-based. - More adoption of continuous, non-invasive, and mobile-linked monitoring tools is likely to shape product competition. - The report positions telehealth and AI-enabled monitoring as the main areas to watch in the next phase of market growth.

The bottom line: - Glucometers are moving from basic blood sugar tools to part of a broader connected-care market, and that transition is supporting sustained double-digit growth.